Issue #6
-
General Session 3 includes results from ZEST study, analysis from TAILORx trial
Nicholas Turner, MD, PhD; Nan Chen, MD; and Pedram Razavi, MD, PhD, were among eight experts reporting results Friday during the third and final General Session of the 2024 San Antonio Breast Cancer Symposium®.
-
Plenary lecturer: Human Breast Cell Atlas charts pathway from healthy tissue to cancer
Walid Khaled, PhD, on Friday discussed work to draw a map of how the breast changes during tumorigenesis and progression.
-
AACR Distinguished Lectureship recipient offers insight into invasive lobular carcinoma research
Steffi Oesterreich, PhD, on Thursday shared highlights from her seminal fundamental and translational research on invasive lobular carcinoma.



